+Compare
IRMD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
520.36M

IRMD iRadimed Corp Forecast, Technical & Fundamental Analysis

a provider of non-magnetic intravenous infusion pump systems

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for IRMD with price predictions
07:00 PM EST Nov 28, 2023

IRMD's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for IRMD moved out of overbought territory on November 06, 2023. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 instances where the indicator moved out of the overbought zone. In of the 21 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 28, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IRMD as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on November 28, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IRMD broke above its upper Bollinger Band on November 03, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

IRMD moved above its 50-day moving average on November 29, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IRMD crossed bullishly above the 50-day moving average on November 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 174 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.978) is normal, around the industry mean (25.181). P/E Ratio (31.949) is within average values for comparable stocks, (79.543). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (8.319) is also within normal values, averaging (44.232).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 5%. For the same Industry, the average monthly price growth was 14%, and the average quarterly price growth was 702%. VVOS experienced the highest price growth at 928%, while SHWGF experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 20%. For the same stocks of the Industry, the average monthly volume growth was 12% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

IRMD is expected to report earnings to fall 15.51% to 36 cents per share on February 07

iRadimed Corp IRMD Stock Earnings Reports
Q4'23
Est.
$0.36
Q3'23
Beat
by $0.07
Q2'23
Beat
by $0.05
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.02
The last earnings report on November 03 showed earnings per share of 43 cents, beating the estimate of 36 cents. With 23.16K shares outstanding, the current market capitalization sits at 520.36M.
A.I.Advisor
published Dividends

IRMD paid dividends on February 21, 2023

iRadimed Corp IRMD Stock Dividends
А quarterly dividend of $1.05 per share was paid with a record date of February 21, 2023, and an ex-dividend date of February 10, 2023. Read more...
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1025 Willa Springs Drive
Phone
+1 407 677-8022
Employees
123
Web
https://www.iradimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEMX35.330.15
+0.43%
Principal Equity Income R1
MSGGX10.920.04
+0.37%
Meridian Small Cap Growth Legacy
FSOAX41.800.08
+0.19%
Fidelity Advisor® Value Strategies A
WFCIX9.89N/A
N/A
Allspring Discovery Large Cap Gr Inst
RWGIX4.57-0.02
-0.44%
Wedgewood Institutional

IRMD and

Correlation & Price change

A.I.dvisor tells us that IRMD and PODD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRMD and PODD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+4.62%
PODD - IRMD
32%
Poorly correlated
+1.72%
ATRC - IRMD
31%
Poorly correlated
-3.30%
ARAY - IRMD
31%
Poorly correlated
+0.38%
MMSI - IRMD
30%
Poorly correlated
+0.18%
ME - IRMD
30%
Poorly correlated
+2.88%
More

Groups containing IRMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+4.62%
detection
(undefined stocks)
58%
Loosely correlated
+1.41%
imaging
(undefined stocks)
47%
Loosely correlated
-0.01%
generic products
(undefined stocks)
39%
Loosely correlated
+0.17%
medical research
(undefined stocks)
38%
Loosely correlated
+0.57%
Medical Specialties
(undefined stocks)
38%
Loosely correlated
+2.61%
More